| Name |
Format |
Description |
Link |
| CCDR: Volume 43-5, May 4, 2017: Implementation science |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-5/assets/pdf/17vol43_5-eng.pdf |
| CCDR: Volume 43-5, May 4, 2017: Implementation science |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-5/assets/pdf/17vol43_5-fra.pdf |
| Vaccine development for Haemophilus influenzae serotype a |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/developing-vaccine-haemophilus-influenzae-serotype-a.html |
| The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/emerging-haemophilus-influenzae-serotype-infection-potential-vaccine.html |
| Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/evaluation-latent-tuberculosis-infection-surveillance-peel-region-ontario-2010-2014.html |
| CCDR: Volume 43-5, May 4, 2017: Implementation science |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017.html |
| Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/mycobacterium-chimaera-infections-post-operative-patients-exposed-heater-cooler-devices.html |
| Bacteremia in children following introduction of conjugated pneumococcal vaccines |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/news.html#a1 |
| Risk assessment for Mycobacterium chimaera |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/news.html#a2 |
| Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-5-may-4-2017/summary-naci-statement-seasonal-influenza-vaccine-2017-2018.html |
| Bacteremia in children following introduction of conjugated pneumococcal vaccines |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/actualites.html#a1 |
| Risk assessment for Mycobacterium chimaera |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/actualites.html#a2 |
| Vaccine development for Haemophilus influenzae serotype a |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/developpement-vaccin-contre-haemophilus-influenzae-serotype-a.html |
| Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010–2014 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/evaluation-surveillance-infection-tuberculeuse-latente-region-peel-ontario-2010-2014.html |
| CCDR: Volume 43-5, May 4, 2017: Implementation science |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017.html |
| The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/infection-emergente-haemophilus-influenzae-serotype-possible-vaccin.html |
| Mycobacterium chimaera infections in post–operative patients exposed toheater–cooler devices: An overview |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/infections-mycobacterium-chimaera-patients-phase-post-operatoire-exposes-echangeurs-thermiques.html |
| Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-5-4-mai-2017/sommaire-declaration-ccni-vaccination-antigrippale-saison-2017-2018.html |